Lv1
28 积分 2024-03-26 加入
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
5小时前
待确认
“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression
1天前
已完结
The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease
1个月前
已完结
Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models
1个月前
已完结
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
1个月前
已完结
ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis
1个月前
已完结
Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021
1个月前
已完结
Sleep disorders in myasthenia gravis: A systematic review on prevalence, clinical associations, and the accuracy of assessment methodologies
1个月前
已完结
Faecal microbiota transplant for Parkinson’s disease: promises and future directions
1个月前
已完结
International Parkinson and Movement Disorder Society Clinical Outcome Assessments are Available in REDCap
1个月前
已完结
皖公网安备34019202002308
